SLC5A2 and chronic kidney disease: Key terms used to carry out the search included “SGLT2 inhibitors,” “glucose,” “diabetes,” “chronic kidney disease,” and “cardiovascular outcomes.” The reference lists of all the included studies were also manually searched for possible inclusion.